NOVARTIS

PHARMACEUTICALS

History and Background:

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.

It is one of the largest pharmaceutical companies by both market cap and sales. Novartis was created in
1996 from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss companies with long
histories. Ciba-Geigy was formed in 1970 by the merger of J. R. Geigy Ltd (founded in Basel in
1758) and CIBA (founded in Basel in 1859). Combining the histories of the merger partners, the
company's effective history spans 250 years.

In 1996, Ciba-Geigy merged with Sandoz; the pharmaceutical and agrochemical divisions of both

companies formed Novartis as an independent entity. Other Ciba-Geigy and Sandoz businesses were
sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand
disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs
businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical
and genetically modified crops business in 2000 with the spinout of Syngenta in partnership
with AstraZeneca, which also divested its agrochemical business.
Novartis is a full member of the European Federation of Pharmaceutical Industries and
Associations (EFPIA), the International Federation of Pharmaceutical Manufacturers and
Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA).

Vision and Mission:

Our vision is to be a trusted leader in changing the practice of medicine. Our mission is to discover new
ways to improve and extend people’s lives. We use science-based innovation to address some of
society’s most challenging healthcare issues. We discover and develop breakthrough treatments and
find new ways to deliver them to as many people as possible. We also aim to provide a shareholder
return that rewards those who invest their money, time and ideas in our company.
Values:
Strong values define our culture and help us execute the Novartis strategy in line with our mission and
vision.
Chairman and CEO:
Joerg Reinhardt (Chairman)
Vasant Narasimhan (CEO)
Products and Services:
As a science-based healthcare company, they strive to develop products that can help change the
practice of medicine. As follows:
 Innovative Medicines:
Our global portfolio of innovative patented medicines includes more than 50 key marketed products,
many of which are among the leaders in their therapeutic areas.

 Generics Medicines and Biosimilars

Our Sandoz Division is a global leader in generic medicines and biosimilars, offering more than 1,000
different types of high-quality, affordable products across a broad range of therapeutic areas. It pioneers
new ways to help people around the world access high-quality medicines.

 Eye Care Devices

The Alcon Division provides innovative products that enhance quality of life by helping people
worldwide see better. Its Surgical and Vision Care businesses offer a wide spectrum of eye care
products.

They provide service in consumer health i.e Animal care, Human health care, skin care centers and cattle
breeding etc.

Turnover:

They have the annual turnover of $172 Billion.

Hierarchy and Environment:

Some of Hierarchy levels:

Product promotion manager

Divisional Sales Manger

Field Manager

Area Sales Manager

Regional sale manager

National Sales Manager

Sales Manager

Director or Chairman

CEO
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group.
Novartis AG owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the
Novartis Group.

Novartis's businesses of are divided into three operating divisions: Pharmaceuticals, Alcon (eye care) and
Sandoz (generics). Novartis operates directly and through dozens of subsidiaries in countries around the
world, each of which fall under one of the divisions, and that Novartis categorizes as fulfilling one or
more of the following functions: "Holding/Finance: the entity is a holding company and/or performs
finance functions for the Group; Sales: the entity performs sales and marketing activities for the Group;
Production: the entity performs manufacturing and/or production activities for the Group; and
Research: the entity performs research and development activities for the Group.
Social Responsibility:
The Healthy Family programs are innovative business models that build local, sustainable healthcare
capabilities for bottom-of-the-pyramid populations. They address social issues that impact access to
healthcare, such as education, infrastructure and distribution. Major works in India, Vietnam and Kenya.

GETZ
PHARMACEUTICAL (PVT) LTD.

History and Background:

Getz Pharma is a member of the Getz Group of Companies, which has a legacy of over 160 years. The
Getz Group was founded in 1852 by a Prussian immigrant Joseph Getz and his three brothers in Lower
Lake, California, and began as a local general store. By the 1870s, the Getz Brothers were marketing
medicines, food products, and consumer goods to customers in Shanghai, Hong Kong, Calcutta and
Madras. Today, the Getz Group is home to more than 12,000 employees worldwide and distributes
agricultural, biomedical, pharmaceutical and technical products and consumer goods in over 50
countries across the world.
 Getz Pharma was initially set up in 1995 by Getz Brothers & Co. Inc. At inception and formation in 1995,
Getz Pharma employed 45 people, and had a small revenue base with no international operations.
Today, Getz Pharma has transformed from a small manufacturing facility to a world-class branded
generic pharmaceutical company with a global outlook.  It employs more than 5,700 highly qualified
people worldwide and has operations in South Asia, Central Asia, South-East Asia, Asia-Pacific, the
Middle East and Africa.

Vision and Mission:

Getz Pharma's mission is to develop, produce and market safe, effective and quality medicines and
healthcare products that will improve the health and quality of life of men, women and children.

Values:

Respect for people: Our principals, employees and suppliers form the basis of our quality and service.
Each shares responsibility for Getz Pharma's reputation as a quality manufacturer and marketer, hence
each deserves to be treated with fairness and dignity.

Respect for our business associates and clients: Getz Pharma seeks long-term and transparent
relationships with its business partners, and enters into all transactions with integrity and trust.

Focus on safe technology: Getz Pharma selects technology that adds real value to its products and
services while keeping the environment safe.

CEO:

Khalid Mehmood (1995 – to the date)

Products and Services:

Getz Pharma is an international research-driven, branded generic pharmaceutical company

specializing in the formulation, development, manufacturing and marketing of a wide range of
quality, affordable medicines.

We manufacture and market brands trusted by healthcare professionals around the world. Our
products are manufactured at our cGMP-compliant facility and tested at our Quality Control
Laboratory which is pre-qualified by the World Health Organization (WHO).

The company currently operates in more than 23 countries in South Asia, Central Asia, South East
Asia, the Middle East and Africa. IMS rates Getz Pharma as the fastest growing pharmaceutical
company within most countries where it operates.

The company’s therapeutic segments in Pakistan include the following:

 Analgesic
 Anti-Asthmatic
 Anti-convulsant
 Anti-Diabetic
Etc.

Turnover:

They have an annual turnover of Rs. 24 Billion.

Hierarchy and Environment:

Levels from Med Rep. to CEO as follows:

Medical Representative

District Sales Manager

Field Manager

Area Sales Manager

Senior Area Sales Manager

National Sales Manager

Sales Manager

Country head (director)

CEO

Recruit the best qualified individuals, and promote on the basis of objective performance appraisals of
the individual’s ability and willingness to take additional responsibility. 

Foster the individual and professional development of employees by providing them continuous training
of the best quality the company can afford. 
Encourage participatory management by ensuring that each staff member has the opportunity to
contribute to decision-making. 
Address staff welfare through fair and competitive salaries and benefits.

Getz Pharma’s strong focus on leadership drives its success. The company strongly believes that leaders
become great, not because of their authority, but because of their ability to empower others.

Getz Pharma’s leadership structure comprises of a management team with the Managing Director/Chief
Executive Officer responsible for running the organization with support from the Executive Committee
which has representation from key areas of Getz Pharma, including Human Resource Development,
Strategic Planning and Business Development, Marketing and Sales, Plant Operations, Quality
Operations, Finance, Information Technology, and Supply Chain. With a sense of responsibility, this team
guides and motivates people, builds their efforts, and makes them challenge their own potential,
resulting in nothing but the very best they have to offer in the work they are carrying out.
The work culture at Getz Pharma involves a participative approach through effective structures and
systems in a sound and stable work environment. Employees are provided guidance, motivation and
timely feedback which collectively develops in them a sense of pride. Since they understand the
importance of their role in the outcome, they take ownership and become valuable team members in
their respective work domains eventually resulting in accomplishing personal as well as organizational
objectives.

Social Responsibility:

Getz Pharma is devoted to the promotion of cultural heritage in the areas of theatre, cinema, music, art
and sports. Efforts that celebrate and promote peace, interfaith and intercultural harmony are
encouraged as they promote literacy, cultural tolerance, support customs and arts, and uplift
communities, thus making lives more fulfilling and enjoyable. Getz Pharma has also sponsored the
publication of books promoting the cultural heritage of Pakistan. This includes sponsoring the printing
and publication of Kalaam-e-Aarifaan, a compilation of priceless sufiana kalaam in Urdu, Punjabi, Saraiki
and Persian languages, which took a decade of hard work.

VARICHEM
PHARMACEUTICALS (PVT) LTD, Zimbabwe

History and Background:

Varichem pharmaceuticals is a wholly Zimbabwean privately owned company established in 1985.

Varichem manufactures and markets a wide range of quality generic pharmaceuticals and related
products. Varichem was born out in 1985 out of the awareness of the acute, sometime critical, need for
reliable cost effective health care products often seriously lacking in the delivery medical care in
Zimbabwe, a country which had dominated the heavy weight pharmaceutical multinationals. The
entrance of Varichem into the health care business signed a new era in the whole pharmaceutical
market by changing the rules of game. Varichem is a wholly Zimbabwean entity, with 100 percent local
shareholding.  Varichem Pharmaceuticals (Pvt). LTD has headquarter in Harare, Zimbabwe.
 Vision and Mission:

To leverage an inclusive workforce to achieve superior business results. To be the preferred entity for
our customers and other stakeholders as we touch lives through the provision of quality healthcare
products and solutions in Africa and beyond.

To create sustainable value through the provision of cost effective healthcare products to meet current
and future demands of the customers and expectations of our stakeholders.

Core Values:

 Integrity
 Transparency
 Passion
 Diligence
 Innovation
 Teamwork
 Quality
 Flexibility

Directors:

Names Appointed Resigned

MR LESLIE PAUL RACZ 31 Dec 1992

Dr VERONICA MARIE KONCZ 31 Dec 1992 30 Jan 2012

MR NEIL MARTIN PETER RACZ 17 Jun 1999

MR ANDREW LESLIE ALEXANDER RACZ 13 Dec 2012

Business Units:

They have three business units:

1) Porchem Private Limited

2) Greenwood Wholesalers and pharmacies
3) Varichem Pharmaceuticals

Products and Services:

The company's products include anti-viral and retroviral, gastrointestinal, analgesic, and anti-infective
drugs. It caters to dispensing doctors, central government medical stores, retail pharmacies, hospitals,
and medical aid societies.

Prochem is proud to be the first manufacturer in the country to have its petroleum jelly certified by the
Standards Association of Zimbabwe.  Being customer focused, we are driven not only to satisfy our
customers but to delight them. We are thus poised and driven to cater for current and future needs of
our customers. The desire to do things right first time  and always, accompanied by the  need to exceed
customer satisfaction has prompted  Prochem (Pvt) Ltd take the noble root of getting certified to ISO
9001: 2008 quality management system.

National Generics t/a Greenwood Wholesalers and Pharmacies is a leading pharmaceutical chain with
vast experience in health and beauty products incorporated and operating in Zimbabwe since 1989. The
leader in delivering health and beauty care. The company currently operates two ( 2 ) regional
wholesales and nine ( 9) retail pharmacies across the length and breadth of Zimbabwe.

 Turnover:

It has annual turnover of US$4 billion and expected to grow to $5.1 billion in 2018. The South African
market is the biggest in Sub-Saharan Africa.

Hierarchy and Environment:

Varichem has managed to forge ahead because of its robust strategies. The company has continually
sought to grow its export market base and this creates new revenue streams. Also the company has
invested in a fully fledged research and development department which is tasked with development and
registration of new products. New products have added to fresh revenues and an improvement in
capacity utilisation with its attendant benefits. Listening to market expectations has also helped the
company to develop products that the market is then willing to accept.

Foreign currency shortages are not peculiar to the pharmaceutical manufacturers. It is a

national problem and manufacturers have not been spared. The delays in processing of
payments lead to delays in receiving raw materials and ultimately this affects production
schedules and product availability. Given the perceived country risk of Zimbabwe, it is almost
impossible to get inputs on credit, most times payments are demanded upfront. The RBZ and
their bankers were doing all they can to ensure that foreign payments for inputs are processed
and it is because of their efforts that the company is still surviving against the backdrop of these
currency shortages. The 94 percent average stocking level in the past six months is also a good
indicator of the efforts being exerted and we hope to improve. According to Mr. Mr Tobias
Dzangare (Varichem group CEO), It is my belief that our capabilities are the combination of several
factors. One, of course, is the quantity, quality, and appropriateness of the equipment and
machinery that we invested in. Other factors include an enabling management
structure, comprehensive systems and procedures to support the business, a sound capital structure
and a culture that promotes individual accountability, demands commitment to client service excellence
and rewards creativity in problem solving.

Ultimately, it is the individuals who serve our clients and customers who are our most valued resource.
Quite simply, it is our people who define our capabilities and our people of whom I am most proud. They
are dedicated, talented, and passionate about the service they perform and collectively they have made
The Varichem Group what it is today.

Social Responsibility:
The Zimbabwean leader in cost-effective generic drug manufacturing.